You are watching a 25-second preview. Log in or Register to keep watching.

Your 25-second preview has ended.

To continue watching, please Log in or Register.

Vivinex Toric Can Rule The Market

Tetsuro Oshika MD

Show Description +

Posted: 7/02/2020

Keywords:

Toric IOLs

•

Vivinex Toric IOL

Up Next

Surgically-Induced Astigmatism: Personal experience with Vivinex multiSert and Clareon AutonoMe when using a 2.2 mm Incision

Khiun F. Tjia, MD

Hoya Research and Innovation Update: Focus on Vivinex multiSert and Vivinex Toric: Panel Discussion

Gerd U. Auffarth, MD, PhD, FEBO, Hiroko Bissen-Miyajima MD, Khiun F. Tjia, MD, Tetsuro Oshika MD

First Clinical Impressions of the Nanex multiSert

Khiun F. Tjia, MD

Nanex multiSert vs. AcrySof IQ in a Rabbit Model

Liliana Werner, MD, PhD

Impact of Decentration

Susana Marcos, PhD

Vivinex multiSert vs. Clareon AutonoMe

Khiun F. Tjia, MD

PCO & Glistening: Vivinex vs. AcrySof

Khiun F. Tjia, MD

Comparison of Two Hydrophobic IOLs

Professor Dominique Monnet

The New Hoya multisert Injector for the Vivinex IOL

Gerd U. Auffarth, MD, PhD

Pseudophakic Monovision

Peter Hoffmann, MD

Comparative Performance Analysis of the Vivinex IOL

Michael Wormstone, PhD

Rotational Stability Comparative Study

Rupert Menapace, MD

Defining and Assessing True Rotational Stability of Toric IOLs

Christina Leydolt, MD

Performance of the multiSert Injector System

Ramin Khoramnia, MD, FEBO

Qube Pro Phacoemulsification System Performance in Hard Cataract Removal (Case 1)

Srinivasan Aravind

Hard Cataract Removal With the Qube Pro Phacoemulsification System (Case 2)

Srinivasan Aravind

Personal Experience with the Vivinex Toric IOL

Hiroko Bissen-Miyajima MD

The Vivinex IOL Platform: Providing long-term optical clarity

Gerd U. Auffarth, MD, PhD, FEBO

Back to All Videos

Vivinex Toric Can Rule The Market

Tetsuro Oshika MD

Posted: 7/02/2020

Keywords:

Toric IOLs

•

Vivinex Toric IOL